{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:42:50Z","timestamp":1790685770820,"version":"4.1.0"},"update-to":[{"DOI":"10.1371\/journal.pntd.0010944","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000}}],"reference-count":67,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Coordination of Superior Level Staff Improvement","award":["Finance Code 001"],"award-info":[{"award-number":["Finance Code 001"]}]},{"name":"Coordination of Superior Level Staff Improvement","award":["88887.637869\/2021-00"],"award-info":[{"award-number":["88887.637869\/2021-00"]}]},{"name":"Coordination of Superior Level Staff Improvement","award":["88887.509223\/2020-00"],"award-info":[{"award-number":["88887.509223\/2020-00"]}]},{"name":"Coordination of Superior Level Staff Improvement","award":["88887.637641\/2021-00"],"award-info":[{"award-number":["88887.637641\/2021-00"]}]},{"name":"Coordination of Superior Level Staff Improvement","award":["88887.637758\/2021-00"],"award-info":[{"award-number":["88887.637758\/2021-00"]}]},{"DOI":"10.13039\/501100006181","name":"Research Support Foundation of the State of Bahia","doi-asserted-by":"crossref","award":["BOL0543\/2020"],"award-info":[{"award-number":["BOL0543\/2020"]}],"id":[{"id":"10.13039\/501100006181","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006181","name":"Research Support Foundation of the State of Bahia","doi-asserted-by":"crossref","award":["BOL0413\/2021"],"award-info":[{"award-number":["BOL0413\/2021"]}],"id":[{"id":"10.13039\/501100006181","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Inova Fiocruz\/VPPCB","award":["VPPCB-008-FIO-18-2-20"],"award-info":[{"award-number":["VPPCB-008-FIO-18-2-20"]}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"crossref","award":["process no. 312195\/2015-0"],"award-info":[{"award-number":["process no. 312195\/2015-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"crossref","award":["process no. 309263\/2020-4"],"award-info":[{"award-number":["process no. 309263\/2020-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Chagas disease (CD) is caused by <jats:italic>Trypanosoma cruzi<\/jats:italic>. The chronic phase of CD is characterized by the presence of IgG anti-<jats:italic>T<\/jats:italic>. <jats:italic>cruzi<\/jats:italic> antibodies; and diagnosis is performed by serological methods. Because there is no reliable test that can be used as a reference test, WHO recommends the parallel use of two different tests for CD serodiagnosis. If results are inconclusive, samples should be subjected to a confirmatory test, e.g., Western blot (WB) or PCR. PCR offers low sensitivity in the chronic phase, whereas few confirmatory tests based on the WB method are commercially available worldwide. Therefore, new diagnostic tools should be evaluated to fill the gap in CD confirmatory tests. In recent years, four chimeric recombinant antigens (IBMP-8.1, IBMP-8.2, IBMP-8.3 and IBMP-8.4) have been evaluated in phase I, II and III studies using ELISA, liquid microarray and immunochromatography with 95\u2013100% accuracy. Given the high diagnostic performance of these antigens, the present study investigated the ability of these molecules to diagnose chronic CD using a WB testing platform.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methodology\/Principal findings<\/jats:title>\n<jats:p>In this study, we analyzed the diagnostic potential of four chimeric antigens using 40 <jats:italic>T<\/jats:italic>. <jats:italic>cruzi<\/jats:italic>-positive, 24-negative, and three additional positive samples for visceral leishmaniasis (i.e., potentially cross-reactive) using WB as the diagnostic platform. Checkerboard titration with different dilutions of antigens, conjugated antigens, and serum samples was performed to standardize all assays. All IBMP antigens achieved 100% sensitivity, specificity, and accuracy, with the exception of IBMP-8.3, which had 100% specificity despite lack of significance, but lower sensitivity (95%) and accuracy (96.9%). No cross-reactivity was observed in samples positive for leishmaniasis.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Conclusions\/Significance<\/jats:title>\n<jats:p>The present phase I (proof-of-concept) study demonstrated the high diagnostic potential of these four IBMP antigens to discriminate between <jats:italic>T<\/jats:italic>. <jats:italic>cruzi<\/jats:italic>-positive and -negative samples, making them candidates for phase II and confirmatory testing with WB.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pntd.0010944","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T18:55:06Z","timestamp":1669661706000},"page":"e0010944","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Western blot using Trypanosoma cruzi chimeric recombinant proteins for the serodiagnosis of chronic Chagas disease: A proof-of-concept study"],"prefix":"10.1371","volume":"16","author":[{"given":"Ramona Tavares","family":"Daltro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily Ferreira","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c2ngelo Ant\u00f4nio Oliveira","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat\u00e1lia Erdens","family":"Maron Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo Maia","family":"Leony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa Carvalho Medrado","family":"Vasconcelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro Ostermayer","family":"Luquetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola Alejandra Fiorani","family":"Celedon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilson Ivo Tonin","family":"Zanchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Gustavo","family":"Regis-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3944-0818","authenticated-orcid":true,"given":"Fred Luciano Neves","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,11,28]]},"reference":[{"key":"pntd.0010944.ref001","first-page":"33","article-title":"Chagas disease in Latin America: an epidemiological update based on 2010 estimates","volume":"90","author":"WHO","year":"2015","journal-title":"Wkly Epidemiol Rec"},{"key":"pntd.0010944.ref002","first-page":"7","article-title":"Preparedness for Chagas disease spreading worldwide.","volume":"9","author":"Q Liu","year":"2020","journal-title":"Infect Dis Poverty"},{"key":"pntd.0010944.ref003","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0140-6736(10)60061-X","article-title":"Chagas disease","volume":"375","author":"A Rassi","year":"2010","journal-title":"Lancet"},{"key":"pntd.0010944.ref004","doi-asserted-by":"crossref","first-page":"e0008445","DOI":"10.1371\/journal.pntd.0008445","article-title":"Acute Chagas disease in Brazil from 2001 to 2018: A nationwide spatiotemporal analysis","volume":"14","author":"EF Santos","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0010944.ref005","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1179\/016164110X12644252260637","article-title":"Neurological manifestations of Chagas\u2019 disease","volume":"32","author":"E C\u00f3rdova","year":"2010","journal-title":"Neurol Res"},{"key":"pntd.0010944.ref006","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1136\/hrt.2008.159624","article-title":"Challenges and opportunities for primary, secondary, and tertiary prevention of Chagas\u2019 disease","volume":"95","author":"A Rassi","year":"2009","journal-title":"Heart"},{"key":"pntd.0010944.ref007","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jclinepi.2008.04.007","article-title":"Diagnostic test accuracy may vary with prevalence: implications for evidence-based diagnosis.","volume":"62","author":"MMG Leeflang","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"pntd.0010944.ref008","doi-asserted-by":"crossref","first-page":"E537","DOI":"10.1503\/cmaj.121286","article-title":"Variation of a test\u2019s sensitivity and specificity with disease prevalence","volume":"185","author":"MMG Leeflang","year":"2013","journal-title":"CMAJ"},{"key":"pntd.0010944.ref009","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.4269\/ajtmh.15-0820","article-title":"Chronic Chagas disease diagnosis: A comparative performance of commercial enzyme immunoassay tests","volume":"94","author":"FLN Santos","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0010944.ref010","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.4269\/ajtmh.13-0391","article-title":"Regional variation in the correlation of antibody and T-cell responses to Trypanosoma cruzi","volume":"90","author":"DL Martin","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0010944.ref011","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.actatropica.2017.09.017","article-title":"Trypanosoma cruzi genetic diversity: Something new for something known about Chagas disease manifestations, serodiagnosis and drug sensitivity","volume":"184","author":"B. Zingales","year":"2018","journal-title":"Acta Trop"},{"key":"pntd.0010944.ref012","author":"World Health Organization","year":"2007","journal-title":"WHO Consultation on international biological reference preparations for Chagas diagnostic tests"},{"key":"pntd.0010944.ref013","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1128\/CVI.00005-09","article-title":"Comparison of recombinant Trypanosoma cruzi peptide mixtures versus multiepitope chimeric proteins as sensitizing antigens for immunodiagnosis","volume":"16","author":"C Camussone","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"pntd.0010944.ref014","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1017\/S0031182018000458","article-title":"Development and assessment of an improved recombinant multiepitope antigen-based immunoassay to diagnose chronic Chagas disease","volume":"145","author":"LM Peverengo","year":"2018","journal-title":"Parasitology"},{"key":"pntd.0010944.ref015","doi-asserted-by":"crossref","first-page":"e0004596","DOI":"10.1371\/journal.pntd.0004596","article-title":"Development of a novel multiplex immunoassay multi-cruzi for the serological confirmation of Chagas disease","volume":"10","author":"E Granjon","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0010944.ref016","doi-asserted-by":"crossref","first-page":"e0005433","DOI":"10.1371\/journal.pntd.0005433","article-title":"Accuracy of chimeric proteins in the serological diagnosis of chronic Chagas disease\u2014a Phase II study","volume":"11","author":"FLN Santos","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0010944.ref017","doi-asserted-by":"crossref","first-page":"e0215623","DOI":"10.1371\/journal.pone.0215623","article-title":"Detection of anti-Trypanosoma cruzi antibodies by chimeric antigens in chronic Chagas disease-individuals from endemic South American countries","volume":"14","author":"RP Del-Rei","year":"2019","journal-title":"PLoS One"},{"key":"pntd.0010944.ref018","doi-asserted-by":"crossref","first-page":"1803515","DOI":"10.1155\/2020\/1803515","article-title":"Development of a new lateral flow assay based on IBMP-8.1 and IBMP-8.4 chimeric antigens to diagnose Chagas disease","volume":"2020","author":"ED Silva","year":"2020","journal-title":"Biomed Res Int"},{"key":"pntd.0010944.ref019","doi-asserted-by":"crossref","first-page":"e0161100","DOI":"10.1371\/journal.pone.0161100","article-title":"Performance assessment of four chimeric Trypanosoma cruzi antigens based on antigen-antibody detection for diagnosis of chronic Chagas disease.","volume":"11","author":"FLN Santos","year":"2016","journal-title":"PLoS One"},{"key":"pntd.0010944.ref020","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1128\/JCM.00851-17","article-title":"Performance assessment of a Trypanosoma cruzi chimeric antigen in multiplex liquid microarray assays","volume":"55","author":"FLN Santos","year":"2017","journal-title":"J Clin Microbiol"},{"key":"pntd.0010944.ref021","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12879-019-3872-z","article-title":"Immune reactivity to Trypanosoma cruzi chimeric proteins for Chagas disease diagnosis in immigrants living in a non-endemic setting","volume":"19","author":"E Dopico","year":"2019","journal-title":"BMC Infect Dis"},{"key":"pntd.0010944.ref022","doi-asserted-by":"crossref","first-page":"e00762","DOI":"10.1128\/JCM.00762-19","article-title":"Cross-reactivity using chimeric Trypanosoma cruzi antigens: diagnostic performance in settings co-endemic for Chagas disease and American cutaneous or visceral leishmaniasis","volume":"57","author":"RT Daltro","year":"2019","journal-title":"J Clin Microbiol"},{"key":"pntd.0010944.ref023","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.cmi.2016.06.001","article-title":"Serodiscordance in chronic Chagas disease diagnosis: a real problem in non-endemic countries","volume":"22","author":"Z Moure","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"pntd.0010944.ref024","first-page":"967","article-title":"Dealing with initial inconclusive serological results for chronic Chagas disease in clinical practice","volume":"31","author":"JS Lapa","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"pntd.0010944.ref025","first-page":"i","article-title":"Control of Chagas disease","volume":"905","author":"WHOE Committee","year":"2002","journal-title":"World Health Organ Tech Rep Ser"},{"key":"pntd.0010944.ref026","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/infdis\/155.3.561","article-title":"Increased specificity of serodiagnosis of Chagas\u2019 disease by detection of antibody to the 72- and 90-kilodalton glycoproteins of Trypanosoma cruzi","volume":"155","author":"V Kirchhoff L","year":"1987","journal-title":"J Infect Dis"},{"key":"pntd.0010944.ref027","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1128\/JCM.38.2.639-642.2000","article-title":"Serologic testing for Trypanosoma cruzi: Comparison of radioimmunoprecipitation assay with commercially available indirect immunofluorescence assay, indirect hemagglutination assay, and enzyme-linked immunosorbent assay kits","volume":"38","author":"D a Leiby","year":"2000","journal-title":"J Clin Microbiol"},{"issue":"Suppl 1","key":"pntd.0010944.ref028","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1590\/S0074-02761999000700057","article-title":"Screening and confirmation in chagas disease serology\u2014a contribution","volume":"94","author":"W Oelemann","year":"1999","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"pntd.0010944.ref029","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1046\/j.1537-2995.1999.39070711.x","article-title":"A recombinant peptide antigen line immunoassay optimized for the confirmation of Chagas\u2019 disease","volume":"39","author":"WM Oelemann","year":"1999","journal-title":"Transfusion"},{"key":"pntd.0010944.ref030","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1128\/JCM.38.2.851-854.2000","article-title":"Serological confirmation of Chagas\u2019 disease by a recombinant and peptide antigen line immunoassay: INNO-LIA Chagas","volume":"38","author":"A Saez-Alqu\u00e9zar","year":"2000","journal-title":"J Clin Microbiol"},{"key":"pntd.0010944.ref031","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S1471-4922(01)01897-9","article-title":"Chagas disease: recombinant Trypanosoma cruzi antigens for serological diagnosis","volume":"17","author":"JF Da Silveira","year":"2001","journal-title":"Trends Parasitol"},{"key":"pntd.0010944.ref032","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1128\/jcm.34.9.2143-2147.1996","article-title":"Immunoblot assay using excreted-secreted antigens of Trypanosoma cruzi in serodiagnosis of congenital, acute, and chronic Chagas\u2019 disease","volume":"34","author":"ES Umezawa","year":"1996","journal-title":"J Clin Microbiol"},{"key":"pntd.0010944.ref033","volume-title":"OpenEpi: Open Source Epidemiologic Statistics for Public Health","author":"AG Dean","year":"2013"},{"key":"pntd.0010944.ref034","author":"World Health Organization, WHO Expert Committee on Biological Standardization","year":"2011","journal-title":"Evaluation of two international reference standards for antibodies to Trypanosoma cruzi in a WHO collaborative study"},{"key":"pntd.0010944.ref035","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"CA Schneider","year":"2012","journal-title":"Nat Methods"},{"key":"pntd.0010944.ref036","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1126\/science.3287615","article-title":"Measuring the accuracy of diagnostic systems","volume":"240","author":"JA Swets","year":"1988","journal-title":"Science"},{"key":"pntd.0010944.ref037","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"JR Landis","year":"1977","journal-title":"Biometrics"},{"key":"pntd.0010944.ref038","doi-asserted-by":"crossref","first-page":"e012799","DOI":"10.1136\/bmjopen-2016-012799","article-title":"STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration","volume":"6","author":"JF Cohen","year":"2016","journal-title":"BMJ Open"},{"key":"pntd.0010944.ref039","first-page":"58","article-title":"Line immunoassay for confirmation and discrimination of human T-cell lymphotropic virus infections in inconclusive Western blot serum samples from Brazil","author":"KR Campos","year":"2019","journal-title":"J Clin Microbiol"},{"key":"pntd.0010944.ref040","article-title":"Performance of commercially available serological screening tests for human T-cell lymphotropic virus infection in Brazil","author":"S Brito V da","year":"2018","journal-title":"J Clin Microbiol"},{"key":"pntd.0010944.ref041","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1080\/14789450.2017.1388167","article-title":"Protein purification and analysis: next generation Western blotting techniques","volume":"14","author":"M Mishra","year":"2017","journal-title":"Expert Rev Proteomics"},{"key":"pntd.0010944.ref042","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1590\/S0074-02761989000300004","article-title":"Trypanosoma cruzi: identification of specific epimastigote antigens by human immune sera","volume":"84","author":"MG Morgado","year":"1989","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"pntd.0010944.ref043","doi-asserted-by":"crossref","first-page":"750","DOI":"10.4269\/ajtmh.1998.59.750","article-title":"Evaluation of the western blot in the confirmatory serologic diagnosis of Chagas\u2019 disease","volume":"59","author":"EM Reiche","year":"1998","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0010944.ref044","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4269\/ajtmh.2012.11-0111","article-title":"Identification of a Western blot pattern for the specific diagnosis of Trypanosoma cruzi infection in human sera","volume":"86","author":"C Riera","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0010944.ref045","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0188-4409(01)00303-4","article-title":"Standardization of micro-enzyme-linked immunosorbent assay (ELISA) and Western blot for detection of Trypanosoma cruzi antibodies using extracts from Mexican strains as antigens","volume":"32","author":"B S\u00e1nchez","year":"2001","journal-title":"Arch Med Res"},{"key":"pntd.0010944.ref046","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1128\/iai.53.1.179-185.1986","article-title":"Analysis of Trypanosoma cruzi antigens bound by specific antibodies and by antibodies to related trypanosomatids","volume":"53","author":"FG Araujo","year":"1986","journal-title":"Infect Immun"},{"key":"pntd.0010944.ref047","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/(SICI)1098-2825(1996)10:6<407::AID-JCLA16>3.0.CO;2-0","article-title":"Changes in isotype composition and antigen recognition of anti-Trypanosoma cruzi antibodies from acute to chronic Chagas disease","volume":"10","author":"ES Umezawa","year":"1996","journal-title":"J Clin Lab Anal"},{"key":"pntd.0010944.ref048","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1590\/0037-8682-0505-2016","article-title":"2 nd Brazilian Consensus on Chagas Disease, 2015","volume":"49","author":"JCP Dias","year":"2016","journal-title":"Rev Soc Bras Med Trop"},{"key":"pntd.0010944.ref049","first-page":"10","article-title":"Evaluation of the chagas Western blot IgG assay for the diagnosis of Chagas disease.","author":"JY Brossas","year":"2021","journal-title":"Pathogens"},{"key":"pntd.0010944.ref050","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.micro.112408.134009","article-title":"Fungal protein production: Design and production of chimeric proteins","volume":"65","author":"PJ Punt","year":"2011","journal-title":"Annu Rev Microbiol"},{"key":"pntd.0010944.ref051","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1128\/JCM.01043-06","article-title":"Design, construction, and evaluation of a specific chimeric antigen to diagnose chagasic infection","volume":"44","author":"S Aguirre","year":"2006","journal-title":"J Clin Microbiol"},{"key":"pntd.0010944.ref052","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1017\/S0031182002002585","article-title":"Characterization of human infection by Leishmania spp. in the Northwest of Argentina: immune response, double infection with Trypanosoma cruzi and species of Leishmania involved","volume":"126","author":"FM Frank","year":"2003","journal-title":"Parasitology"},{"key":"pntd.0010944.ref053","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1086\/315165","article-title":"Multiepitope synthetic peptide and recombinant protein for the detection of antibodies to Trypanosoma cruzi in patients with treated or untreated Chagas\u2019 disease","volume":"181","author":"RL Houghton","year":"2000","journal-title":"J Infect Dis"},{"key":"pntd.0010944.ref054","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.diagmicrobio.2010.03.013","article-title":"Comparison of the analytic sensitivities of a recombinant immunoblot assay and the radioimmune precipitation assay for the detection of antibodies to Trypanosoma cruzi in patients with Chagas disease","volume":"67","author":"DO Shah","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"pntd.0010944.ref055","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.4269\/ajtmh.17-0727","article-title":"Highly accurate chimeric proteins for the serological diagnosis of chronic Chagas disease: A latent class analysis","volume":"99","author":"FLN Santos","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0010944.ref056","doi-asserted-by":"crossref","first-page":"112573","DOI":"10.1016\/j.bios.2020.112573","article-title":"Impedimetric immunosensor for rapid and simultaneous detection of Chagas and visceral leishmaniasis for point of care diagnosis","volume":"169","author":"TAR Cordeiro","year":"2020","journal-title":"Biosens Bioelectron"},{"key":"pntd.0010944.ref057","doi-asserted-by":"crossref","first-page":"e0007545","DOI":"10.1371\/journal.pntd.0007545","article-title":"Performance of recombinant chimeric proteins in the serological diagnosis of Trypanosoma cruzi infection in dogs","volume":"13","author":"LM Leony","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0010944.ref058","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3390\/bios11080289","article-title":"Stability assessment of four chimeric proteins for human Chagas disease immunodiagnosis","volume":"11","author":"PAF Celedon","year":"2021","journal-title":"Biosensors"},{"key":"pntd.0010944.ref059","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.actatropica.2010.08.018","article-title":"Western blotting method (TESAcruzi) as a supplemental test for confirming the presence of anti-Trypanosoma cruzi antibodies in finger prick blood samples from children aged 0\u20135 years","volume":"117","author":"AF Frade","year":"2011","journal-title":"Brazil. Acta Trop"},{"key":"pntd.0010944.ref060","first-page":"644","article-title":"Western blot technique standardization for specific diagnosis of Chagas disease using excretory-secretory antigens of Trypanosoma cruzi epimastigotes","volume":"31","author":"H Escalante","year":"2014","journal-title":"Rev Peru Med Exp Salud Publica"},{"key":"pntd.0010944.ref061","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1186\/s13071-015-1072-2","article-title":"Highly discordant serology against Trypanosoma cruzi in central Veracruz, Mexico: role of the antigen used for diagnostic","volume":"8","author":"D Guzm\u00e1n-G\u00f3mez","year":"2015","journal-title":"Parasit Vectors"},{"key":"pntd.0010944.ref062","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0188-4409(99)00062-4","article-title":"American trypanosomiasis (Chagas\u2019 disease) and blood banking in Mexico city.","volume":"30","author":"VM Monte\u00f3n-Padilla","year":"1999","journal-title":"Arch Med Res"},{"key":"pntd.0010944.ref063","first-page":"6","article-title":"Identification of immunodominant components of an isolate of Trypanosoma cruzi by immunoblot and its standardization for diagnostic purposes","volume":"151","author":"E Torres-Guti\u00e9rrez","journal-title":"Gac Med Mex"},{"key":"pntd.0010944.ref064","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.actatropica.2019.02.014","article-title":"First report of family clusters of Chagas disease seropositive blood donors in Mexico City and their epidemiological relevance","volume":"193","author":"B Espinoza","year":"2019","journal-title":"Acta Trop"},{"key":"pntd.0010944.ref065","first-page":"862","article-title":"Immunoblot analysis of trypomastigote excreted-secreted antigens as a tool for the characterization of Trypanosoma cruzi strains and isolates","volume":"86","author":"N Kesper","year":"2000","journal-title":"J Parasitol"},{"key":"pntd.0010944.ref066","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/365403","article-title":"High molecular weight proteins of Trypanosoma cruzi reduce cross-reaction with Leishmania spp. in serological diagnosis tests","volume":"2014","author":"AY Cervantes-Land\u00edn","year":"2014","journal-title":"Biomed Res Int"},{"key":"pntd.0010944.ref067","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2249.1994.tb06104.x","article-title":"Cross-reactivity studies and differential serodiagnosis of human infections caused by Trypanosoma cruzi and Leishmania spp; use of immunoblotting and ELISA with a purified antigen (Ag163B6).","volume":"97","author":"EL Malchiodi","year":"1994","journal-title":"Clin Exp Immunol"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0010944","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0010944","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T18:47:36Z","timestamp":1670525256000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0010944"}},"subtitle":[],"editor":[{"given":"Andrea","family":"Angheben","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,11,28]]},"references-count":67,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0010944","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0010944","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,28]]}}}